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Ready for human spinal cord repair?
We are in an exciting time where, based on successfully
established animal models, a partial repair of the damaged
human CNS appears to be feasible. A paper in the present
issue of Brain (Mackay-Sim et al., 2008) deals with the
outcome after transplantation of olfactory ensheathing cells
(OEC) in subjects with chronic spinal cord injury. An
earlier report described the surgical and safety procedures
in this trial (Feron et al., 2005).
Presently, rehabilitation of spinal cord injury is limited
to exploiting neuronal plasticity by functional training
(Dietz, 2002). The combination of functional training and
regenerative therapies, even if only limited structural repair
is achieved, would certainly make an improved impact on
outcome. There is an impressive number of promising
approaches for inducing regeneration or limiting neuronal
damage by neuroprotective treatments based on rodent
experiments (for review see Raineteau and Schwab, 2001;
Deumens et al., 2005; Ramer et al., 2005; Dietz and Curt,
2006). One is the application of regeneration-facilitating
OEC at the lesion site. Convincing evidence was found that
this approach leads to some spinal cord repair in rodent
spinal cord injury (Li et al., 1997; Ramon-Cueto et al.,
2000; Barnett and Chang, 2004).
The present article (Mackay-Sim et al., 2008) reports on the
effect of this approach in six chronic complete (ASIA A)
spinal cord injury subjects (phase I/IIa design) with regular
follow-up using clinical, electrophysiological (MEP), imaging
(MRI) and functional (Functional Independence Measure,
FIM) examinations over 3 years. Thus, the present study, in
contrast to other OEC trials (Huang et al., 2003; Lima et al.,
2006), was carefully designed on the basis of standards
established during the past few years (Steeves et al., 2007).
Such a study design is in line with the consensus that clinical
examinations alone are insufficient reliably to monitor any
therapeutic effect of a new interventional therapy (Curt et al.,
2004). Additional neurophysiological and functional exam-
inations allow for some differentiation between compensa-
tion, neuronal plasticity and regeneration as principal factors
underlying an improvement of function after a spinal cord
injury (Curt et al., 2008). Meanwhile, the Spinal Cord Inde-
pendence Measure (SCIM) has been established for func-
tional testing in spinal cord injury subjects (Catz et al., 2001).
The results described by Mackay et al. (2008) must be
considered preliminary because of the small number of
spinal cord injury subjects included. In addition, the ther-
apeutic effect of cell transplantation on outcome was not
the primary goal of this study, although a comparison was
made with a control group of spinal cord injury subjects.
Overall, there were no adverse findings 3 years after
autologous OEC transplantation. Only one spinal cord
injury subject showed some sensory gain, but no functional
recovery; in all other treated subjects no change in clinical
and functional tests was detected. Also, the imaging and
electrophysiological examinations remained unchanged over
the course of the study. For this category of a complete
spinal cord injury (ASIA A) such an outcome corresponds
to the natural history (Curt et al., 2008). The results appear
disappointing in view of the promising animal experiments.
How can this be explained? During the last 10 years we
have become increasingly aware of the problems associated
with such translational studies, due to the complexity of
this field (Dietz and Curt, 2006). There are several
interpretations that might be offered.
First, the adequacy of the animal spinal cord injury
model on which the clinical study is based has to be
considered. There are some animal models that fit poorly
with the human condition. For example, the frequently
used transection model (cf. Raineteau and Schwab, 2001;
Bennett et al., 2004; Klapka et al., 2005) does not reflect the
human condition, where the contusional lesion usually
extends over several segments of the spinal cord. However,
a contusion rat model shows similar electrophysiological
and imaging results as well as outcome in function as
human spinal cord injury (Metz et al., 2000). Similarly, the
spastic movement disorder after spinal cord injury never
shows a motoneuronal hyperactivity (Dietz and Sinkjaer,
2007) as described for the rat with a sacral spinal cord
injury (Bennett et al., 2004).
Second, thoracic lesions are usually studied in animal
models (Gensel et al., 2006), whereas injury to the cervical
cord is most common in humans (Curt et al., 2008). Also, in
the trial discussed here (Mackay-Sim et al., 2008), spinal cord
injury subjects with thoracic lesions were included in order to
minimize the risk of any additional loss of function as a result
of this procedure, with the consequence of recruitment
difficulties. In the cervical lesion, every segment gained would
have a great impact on function, whereas in subjects with
thoracic damage, improvement of locomotor function can
only be achieved if regenerating fibres make contact with the
long propriospinal neurons (Raineteau and Schwab, 2001).
However, cervical and thoracolumbar spinal cord injuries are
always associated with damage to the peripheral nervous
system (up to 40% of paresis might be due to a damage of
motoneurons and roots; Collazos-Castro et al., 2005). This
deficit would possibly not be affected by an intervention
directed at spinal tract regeneration.
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Third, new interventional therapies are frequently applied
in chronic spinal cord injury subjects aiming to achieve
clinical stability (Mackay-Sim et al., 2008). However, recent
studies in chronic spinal cord injury describe demyelination
around the injury cavities (Guest et al., 2005), scar
formation (Klapka et al., 2005) and degradation of spinal
neuronal function below the level of the lesion (Dietz and
Muller, 2004). Thus, even if regeneration of tract fibres is
achieved through intervention, this may not necessarily be
matched by functional improvement. Therefore, for most
current studies, early intervention is recommended (cf.
Dietz and Curt, 2006).
Fourth, no functional training was performed in the
present trial (Mackay-Sim et al., 2008). In contrast to
humans, rodents train themselves automatically after spinal
cord injury. There is evidence that functional training does
facilitate appropriate re-connections by regenerating fibre
tracts after spinal cord injury (Edgerton et al., 1997; de
Leon et al., 1999; Dietz and Harkema, 2004).
Fifth, a number of mechanisms after spinal cord injury
prevent a spontaneous regeneration of fibre tracts (e.g. scar
formation and expression of Nogo protein and chondroitin
sulphate). This has prompted corresponding approaches to
overcome these hurdles and to induce/facilitate regenera-
tion of damaged fibres (for review see Raineteau and
Schwab, 2001; Ramer et al., 2005; Dietz and Curt, 2006).
Therefore, as exemplified in the rat, the use of comple-
mentary approaches involving Schwann cell bridges, OEC
and chondroitinase might be applied to human subjects in
the future in order to enhance the number of regenerating
fibres and improve the prospects of functional recovery
(Fouad et al., 2005).
The last point concerns problems, which are well
discussed in the paper of Mackay-Sim et al. (2008), of
achieving an optimal versus an ethically acceptable design
including the issue of whether or how to include sham-
surgical controls. With the availability of a detailed
description of the natural history of spinal cord injury in
a great number of subjects (Curt et al., 2008), the control
group in a trial can be kept relatively small.
Based on the above points we can learn important
lessons from the work of Mackay-Sim et al. (2008) and
hope to make such trials more successful in the future.
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